![](https://d3ilqtpdwi981i.cloudfront.net/88FffOiHJz56QdKZJfyjBRSlwQY=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/1d/9c/6b/1d9c6b6a-82e9-4f7d-9fde-6259f6294dd9/thumbnail_d2fb6ff7-261f-47b0-8267-49ee6b00058e.jpg)
Acute and subacute intraperitoneal doses of fumonisin B1 (FB1) were administered to test the efficacy of the FB1-glucose reaction products in detoxifying FB1 in swine. In the acute study at 11 µmol of FB1/kg of body weight, five of six pigs administered FB1 and four of six pigs administered FB1- glucose died from acute pulmonary edema. Analysis of weight gain, serum aspartate aminotransferase and γ-glutamyltransferase, total cholesterol, and pathological evaluation did not provide evidence of protection against FB1 toxicity by the FB1-glucose reaction products. In the subacute study at 5.5 µmol of FB1/kg of body weight, one pig administered FB1 died from liver damage. Analysis of serum aspartate aminotransferase, γ-glutamyltransferase, and total bilirubin showed protection against FB1 toxicity by the FB1-glucose reaction products. The levels of sphinganine and sphinganine/sphingosine ratios in serum and liver as well as pathologic findings provided definitive evidence of protection against the FB1 toxic effects by this detoxification procedure (p < 0.05).
Available at: http://works.bepress.com/suzanne_hendrich/24/
Reprinted with permission from Journal of Agricultural and Food Chemistry , 52(25):7732-7739. doi:10.1021/jf048981c. Copyright 2004 American Chemical Society.